| Detailed information |
|---|
| CancerLivER ID | 2430 |
| Biomarker | RGS-1 |
| Biomarker Name/Symbol (given in Publication) | RGS-1 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potenial Diagnostic marker for HCC; but not validated on independent patient cohort |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC than non-tumor (with fold change of 8.5) |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 16463013 |
| Type of Biomarker | Diagnostic |
| Pathway | GTPase activator activity and calmodulin binding |
| Cohort | 24 pairs of HCC tissues and adjacent non-tumor tissues |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2006 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |